Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Sign on to:
My Account
Receive email
updates
Edit Profile
CMU Intellectual Repository
Search
Search:
All of CMUIR
Graduate School (Theses/IS)
Sciences and Technology
Health Sciences
Humanities and Social Sciences
Research Institutes
Academic Support Units
Social Engagement
Theses/IS
Untitled
Untitled
Untitled
Untitled
for
Current filters:
Title
Author
Subject
Date Issued
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 13 (Search time: 0.007 seconds).
previous
1
2
next
Item hits:
Issue Date
Title
Author(s)
1-Aug-2013
Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study
Yi Long Wu
;
Masahiro Fukuoka
;
Tony S.K. Mok
;
Nagahiro Saijo
;
Sumitra Thongprasert
;
James C.H. Yang
;
Da Tong Chu
;
Jin Ji Yang
;
Yuri Rukazenkov
1-May-2013
Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis
Chee Khoon Lee
;
Chris Brown
;
Richard J. Gralla
;
Vera Hirsh
;
Sumitra Thongprasert
;
Chun Ming Tsai
;
Eng Huat Tan
;
James Chung Man Ho
;
Da Tong Chu
;
Adel Zaatar
;
Jemela Anne Osorio Sanchez
;
Vu Van Vu
;
Joseph Siu Kie Au
;
Akira Inoue
;
Siow Ming Lee
;
Val Gebski
;
James Chih Hsin Yang
20-Jul-2011
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS)
Masahiro Fukuoka
;
Yi Long Wu
;
Sumitra Thongprasert
;
Patrapim Sunpaweravong
;
Swan Swan Leong
;
Virote Sriuranpong
;
Tsu Yi Chao
;
Kazuhiko Nakagawa
;
Da Tong Chu
;
Nagahiro Saijo
1-Jan-2012
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
Jun Ho Yi
;
Sumitra Thongprasert
;
Jeeyun Lee
;
D. C. Doval
;
Se Hoon Park
;
Joon Oh Park
;
Young Suk Park
;
Won Ki Kang
;
Ho Yeong Lim
10-Jun-2012
Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: A phase III trial
Giorgio V. Scagliotti
;
Maciej Krzakowski
;
Aleksandra Szczesna
;
Janos Strausz
;
Anatoly Makhson
;
Martin Reck
;
Rafal F. Wierzbicki
;
Istvan Albert
;
Michael Thomas
;
Jose Elias Abrao Miziara
;
Zsolt S. Papai
;
Nina Karaseva
;
Sumitra Thongprasert
;
Elsa Dalmau Portulas
;
Joachim Von Pawel
;
Ke Zhang
;
Paulina Selaru
;
Lesley Tye
;
Richard C. Chao
;
Ramaswamy Govindan
1-Oct-2013
Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia
Shukui Qin
;
Yuxian Bai
;
Ho Yeong Lim
;
Sumitra Thongprasert
;
Yee Chao
;
Jia Fan
;
Tsai Shen Yang
;
Vajarabhongsa Bhudhisawasdi
;
Won Ki Kang
;
Yu Zhou
;
Jee Hyun Lee
;
Yan Sun
1-Aug-2016
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer
Tony Mok
;
Guia Ladrera
;
Vichien Srimuninnimit
;
Virote Sriuranpong
;
Chong Jen Yu
;
Sumitra Thongprasert
;
Jennifer Sandoval-Tan
;
Jin Soo Lee
;
Fatima Fuerte
;
David S. Shames
;
Barbara Klughammer
;
Matt Truman
;
Pablo Perez-Moreno
;
Yi Long Wu
15-Jul-2015
Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy
Tony Mok
;
Yi Long Wu
;
Jin Soo Lee
;
Chong Jen Yu
;
Virote Sriuranpong
;
Jennifer Sandoval-Tan
;
Guia Ladrera
;
Sumitra Thongprasert
;
Vichien Srimuninnimit
;
Meilin Liao
;
Yunzhong Zhu
;
Caicun Zhou
;
Fatima Fuerte
;
Benjamin Margono
;
Wei Wen
;
Julie Tsai
;
Matt Truman
;
Barbara Klughammer
;
David S. Shames
;
Lin Wu
1-Jan-2017
Efficacy and safety of first-line necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in East Asian patients with stage IV squamous non-small cell lung cancer: A subgroup analysis of the phase 3, open-label, randomized SQUIRE study
Keunchil Park
;
Eun Kyung Cho
;
Maximino Bello
;
Myung Ju Ahn
;
Sumitra Thongprasert
;
Eun Kee Song
;
Victoria Soldatenkova
;
Henrik Depenbrock
;
Tarun Puri
;
Mauro Orlando
1-Feb-2017
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC
Yi Long Wu
;
Nagahiro Saijo
;
Sumitra Thongprasert
;
J. C.H. Yang
;
Baohui Han
;
Benjamin Margono
;
Busayamas Chewaskulyong
;
Patrapim Sunpaweravong
;
Yuichiro Ohe
;
Yukito Ichinose
;
Jin Ji Yang
;
Tony S.K. Mok
;
Helen Young
;
Vincent Haddad
;
Yuri Rukazenkov
;
Masahiro Fukuoka
Discover
Author
7
Yi Long Wu
5
Masahiro Fukuoka
4
Nagahiro Saijo
3
Da Tong Chu
3
Tony Mok
3
Virote Sriuranpong
2
Akira Inoue
2
Barbara Klughammer
2
Benjamin Margono
2
Caicun Zhou
.
next >
Date issued
1
2019
3
2017
1
2016
1
2015
3
2013
2
2012
1
2011
1
2010